House concurred with Senate amendments. This bill changes the category of medications to which the bill applies from "orally administered" medications to "self administered" medications, requires health plans to offer self administered drugs on a basis at least comparable to chemotherapy medications administered by health providers or facilities (the original bill required the medications to be offered on a comparable basis to chemotherapy medications administered intravenously or by injection) and allows health plans to administer a formulary or preferred drug list. This bill requires health plans that cover chemotherapy treatment to provide coverage for self-administered chemotherapy drugs on a basis at least comparable to drugs administered by a provider or facility. This bill each health plan offering individual or small group products that provides coverage for prescribed, self-administered anticancer.